Data Collective IV’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$30.1M Hold
2025
Q1
$31.4M Hold
2024
Q4
$40.2M Hold
2024
Q3
$39.2M Hold
2024
Q2
$44.6M Hold
2024
Q1
$59.2M Hold
2023
Q4
$58.6M Hold
2023
Q3
$45.4M Hold
2023
Q2
$44.4M Hold
2023
Q1
$39.6M Hold
2022
Q4
$45.8M Hold
2022
Q3
$63.2M Hold
2022
Q2
$48.4M Hold
2022
Q1
$42.5M Hold
2021
Q4
$102M Buy